Yi Yi Shen

Part of Zhejiang Yatai Pharmaceutical Co., Ltd., Shanghai Xingaofeng Biological Medicine Co., Ltd. is a biotechnology company based in Shanghai, CN. Shanghai Xingaofeng Biological Medicine Co. was acquired by Zhejiang Yatai Pharmaceutical Co., Ltd. from Green Villa Holdings Ltd. on December 02, 2015 for $141.84 million. The Chinese company engages in the development of biotechnology. The company was founded in 2007. The CEO is Li Yun Wang.

Shanghai Newsummit Biopharma Group Co., Ltd. provides new drug development process solutions. Its services include pre-clinical development, clinical development, and assistance in the preparation of the regulatory submission of investigational new drug and new drug applications. The company also involves in the provision of technical services for medical devices research. Shanghai Newsummit Biopharma Group was founded by Jun Ren in 2001 and is headquartered in Shanghai, China.

Part of Zhejiang Yatai Pharmaceutical Co., Ltd., Shanghai Xingaofeng Biological Medicine Co., Ltd. is a biotechnology company based in Shanghai, CN. Shanghai Xingaofeng Biological Medicine Co. was acquired by Zhejiang Yatai Pharmaceutical Co., Ltd. from Green Villa Holdings Ltd. on December 02, 2015 for $141.84 million. The Chinese company engages in the development of biotechnology. The company was founded in 2007. The CEO is Li Yun Wang.

Part of Zhejiang Yatai Pharmaceutical Co., Ltd., Shanghai Xingaofeng Biological Medicine Co., Ltd. is a biotechnology company based in Shanghai, CN. Shanghai Xingaofeng Biological Medicine Co. was acquired by Zhejiang Yatai Pharmaceutical Co., Ltd. from Green Villa Holdings Ltd. on December 02, 2015 for $141.84 million. The Chinese company engages in the development of biotechnology. The company was founded in 2007. The CEO is Li Yun Wang.